...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Nonprofit Think Tank

,,,,,,,lmao,,,,,I assume this rumor is from the same source or sources all the other rumors came from,,,,,it holds about as much water as a reed basket imo,,,,,,you aint taking a penny off a billionaire,,,,this science is going forward, its just a question as to what the time line is,,,,,,Hepa,,Dart and others want their investment dollars working,,not sitting around lollygagging,,,,,,,,you can bet your bottom dollar on that,,,,,!

Share
New Message
Please login to post a reply